Re: Maria S. Lindgren, Peter Bue, Nessn Azawi, et al. The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–muscle-invasive Bladder Cancer—A Randomized Controlled Trial. Eur Urol 2020;78:856–62

Controlled Trial ◽

Invasive Bladder Cancer ◽

Short Term ◽

Randomized Controlled ◽

Muscle Invasive ◽

Intravesical Instillations

Reply to Claudia Signorini and Massimo Maffezzini’s Letter to the Editor re: Maria S. Lindgren, Peter Bue, Nessn Azawi, et al. The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non–muscle-invasive Bladder Cancer—A Randomized Controlled Trial. Eur Urol 2020;78:856–62

European Urology ◽

10.1016/j.eururo.2021.02.001 ◽

2021 ◽

Author(s):

Maria S. Lindgren ◽

Jørgen B. Jensen

Keyword(s):

Bladder Cancer ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Short Term ◽

Randomized Controlled ◽

Letter To The Editor ◽

Muscle Invasive ◽

Intravesical Instillations

1669 INTRAVESICAL ADJUVANT ELECTROMOTIVE MITOMYCIN-C IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER A RANDOMIZED CONTROLLED TRIAL

The Journal of Urology ◽

10.1016/j.juro.2012.02.1527 ◽

2012 ◽

Vol 187 (4S) ◽

Cited By ~ 1

Author(s):

Savino Mauro Di Stasi ◽

Cristian Verri ◽

Emanuele Liberati ◽

Francesco Micali ◽

Francesco Masedu ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Randomized Controlled ◽

Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: A single center randomized controlled trial

International Journal of Urology ◽

10.1111/j.1442-2042.2012.03174.x ◽

2012 ◽

Vol 20 (4) ◽

pp. 399-403 ◽

Cited By ~ 30

Author(s):

Alessandro Del Rosso ◽

Gianna Pace ◽

Stefano Masciovecchio ◽

Pietro Saldutto ◽

Giuseppe Paradiso Galatioto ◽

...

Keyword(s):

Bladder Cancer ◽

Transurethral Resection ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Single Center ◽

Randomized Controlled ◽

PD17-10 MONOPOLAR VERSUS BIPOLAR TRANSURETHRAL RESECTION OF NON-MUSCLE INVASIVE BLADDER CANCER: A SINGLE CENTER RANDOMIZED CONTROLLED TRIAL

The Journal of Urology ◽

10.1016/j.juro.2015.02.667 ◽

2015 ◽

Vol 193 (4S) ◽

Cited By ~ 1

Author(s):

Ahmed M. Mansour ◽

Ahmed A. Shokeir ◽

Mohammed Tharwat ◽

Bedeir Ali-El-Dein ◽

Yasser Osman

Keyword(s):

Bladder Cancer ◽

Transurethral Resection ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Single Center ◽

Randomized Controlled ◽

Intravesical adjuvant electromotive mitomycin-C in patients with primary intermediate-risk urothelial non-muscle invasive bladder cancer: A randomized controlled trial

European Urology Supplements ◽

10.1016/s1569-9056(19)33633-4 ◽

2019 ◽

Vol 18 (9) ◽

pp. e3248

Author(s):

S. Di Stasi ◽

V. Ambrosi Grappelli ◽

V. Pagliarulo ◽

C. Fede Spicchiale ◽

A. Giannantoni ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Intermediate Risk ◽

Randomized Controlled ◽

The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011)

Trials ◽

10.1186/1745-6215-13-228 ◽

2012 ◽

Vol 13 (1) ◽

Cited By ~ 14

Author(s):

Clare Moynihan ◽

◽

Rebecca Lewis ◽

Emma Hall ◽

Emma Jones ◽

...

Keyword(s):

Bladder Cancer ◽

Qualitative Study ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Bladder Preservation ◽

Deficit Model ◽

Randomized Controlled ◽

HIVEC HR: Chemohyperthermia with mitomycin C vs BCG for high-risk non-muscle invasive bladder cancer. Preliminary results from a randomized controlled trial

European Urology Supplements ◽

10.1016/s1569-9056(19)30563-9 ◽

2019 ◽

Vol 18 (1) ◽

pp. e768-e770 ◽

Cited By ~ 1

Author(s):

D.A. González Padilla ◽

A. González Díaz ◽

N. Miranda-Utrera ◽

F. De La Rosa Kehrmann ◽

F. Villacampa-Aubá ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Preliminary Results ◽

Randomized Controlled ◽

Editorial Comment to Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: A single center randomized controlled trial

International Journal of Urology ◽

10.1111/j.1442-2042.2012.03180.x ◽

2012 ◽

Vol 20 (4) ◽

pp. 404-404

Author(s):

Angelo Naselli

Keyword(s):

Bladder Cancer ◽

Editorial Comment ◽

Transurethral Resection ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

Single Center ◽

Randomized Controlled ◽

Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation

World Journal of Urology ◽

10.1007/s00345-018-2196-8 ◽

2018 ◽

Vol 36 (6) ◽

pp. 889-895 ◽

Cited By ~ 4

Author(s):

Ryuta Tanimoto ◽

Takashi Saika ◽

Shin Ebara ◽

Yasuyuki Kobayashi ◽

Ryoji Nasu ◽

...

Keyword(s):

Bladder Cancer ◽

Controlled Trial ◽

Intravesical Chemotherapy ◽

Invasive Bladder Cancer ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽

Transurethral en-bloc hydrodissection for non-muscle invasive bladder cancer: Results of a randomized controlled trial

European Urology Supplements ◽

10.1016/s1569-9056(17)30713-3 ◽

2017 ◽

Vol 16 (3) ◽

pp. e1143-e1144 ◽

Cited By ~ 2

Author(s):

G. Gakis ◽

A. Karl ◽

S. Bertz ◽

M. Burger ◽

H.-M. Fritsche ◽

...

Keyword(s):

Bladder Cancer ◽

Controlled Trial ◽

Invasive Bladder Cancer ◽

En Bloc ◽

Randomized Controlled ◽